Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports

Tumour necrosis factor (TNF)-α blocking agents have revolutionized the treatment of psoriasis and psoriatic arthritis. Concerns remain about increased susceptibility to infection and onset of malignancies, and the use of TNF-α agents in patients with HIV infection or undergoing immunosuppressant tre...

Descripción completa

Detalles Bibliográficos
Autores principales: De Simone, Clara, Perino, Francesca, Caldarola, Giacomo, D’Agostino, Magda, Peris, Ketty
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Immuno-Mediated Diseases And Comorbities
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536537/
https://www.ncbi.nlm.nih.gov/pubmed/27683143
http://dx.doi.org/10.1177/0300060515593250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536537/
https://www.ncbi.nlm.nih.gov/pubmed/27683143
http://dx.doi.org/10.1177/0300060515593250

Ejemplares similares